Stimulated human leukocytes cause activating mutations in the K-ras proto-oncogene

Oncogene

Volumn 14, Issue 23, 1997, Pages 2803-2808

  Jackson, Janis Harline ^a   Vollenweider, Maya ^a   Hill, Jennifer ^a   Rodriguez, Henry ^a   Schwabacher, Alan W ^b   Mitra, Gopa ^c   Kuo, Chao Yu ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c PROMEGA CORPORATION   (United States)

Author keywords

Carcinogenesis; DNA damage; Inflammation; K ras; Oxidants

Indexed keywords

DNA; HYDROXYL RADICAL;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKOCYTE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTO ONCOGENE; RAT;

3T3 CELLS; ANIMALS; DEOXYGUANOSINE; DNA DAMAGE; DNA, NEOPLASM; GENES, RAS; HUMANS; HYDROXYL RADICAL; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MICE; MUTATION; PLASMIDS; PURINES; RAS PROTEINS; TRANSFECTION; XANTHINE OXIDASE;

ANIMALIA;

EID: 0030878786     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201118     Document Type: Article

References (47)

1. Babior BM. (1978). New Eng. J. Med.. 298, 659-668.
2. Barbacid M. (1987). Ann. Rev. Biochem., 56, 779-828.
3. Basu AK, Loechler EL, Leadon SA and Essigmann JM. (1989). Proc. Natl. Acad. Sci. USA, 86, 7677-7681.
4. Berkow RL, Tzeng DY, Williams LV and Baehner RL. (1983). J. Lab. Clin. Med., 102, 732-742.
5. Birnboim HC. (1982). Science, 215, 1247-1249.
6. Bodepudi V, Shibutani S and Johnson F. (1992). Chem. Res. In Tox., 5, 608-617.
7. Bos JL. (1989). Cancer Res., 49, 4682-4689.
8. Cepko CL, Roberts BE and Mulligan RC. (1984). Cell, 37, 1053-1062.
9. Cheng KC, Cahill DS, Kasai H, Nishimura S and Loeb LA. (1992). J. Biol. Chem., 267, 166-172.
10. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ and Stickler GB. (1971). New Eng. J. Med., 285, 17-21.
11. Floyd RA, Watson JJ, Harris J, West M and Wong PK. (1986). Biochem. Biophys. Res. Commun., 137, 841-846.
12. Frenkel K, Chrzan K, Troll W, Teebor GW and Steinberg JJ. (1986). Cancer Res., 46, 5533-5540.
13. Furth ME, Davis LJ, Fleurdelys B and Scolnick EM. (1982). J. Virol., 43, 294-304.
14. Greenstein AJ, Sacher DB, Smith H, Pucillo A, Papatestas AE, Kreel I, Geller SA, Janowitz HD and Aufses AH Jr. (1979). Gastroenterology, 77, 290-294.
15. Guschlbauer W, Duplaa A-M, Guy A, Teoule R and Fazakerley GV. (1991). Nucleic Acids Res., 19, 1753-1758.
16. Halliwell B. (1987). FASEB J., 1, 358-364.
17. Halliwell B and Aruoma OI. (1991). FEBS. LETT., 281, 9-19.
18. Hayes RC, Petrullo LA, Huang H, Wallace SS and LeClerc JE. (1988). J. Mol. Biol., 201, 239-246.
19. Higuchi RG and Ochman H. (1989). Nucleic Acids Res., 17, 5865.
20. Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE and Der CJ. (1990). Proc. Natl. Acad. Sci. USA, 87, 3042-3046.
21. Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AF, Cochrane CG and Dizdaroglu M. (1989). J. Clin. Invest., 84, 1644-1649.
22. Jackson JH, Li JW, Buss JE, Der CJ and Cochrane CG. (1994). Proc. Natl. Acad. Sci. USA, 91, 12730-12734.
23. Kamiya H, Miura K, Ishikawa H, Inoue H, Nishimura S and Ohtsuka E. (1992). Cancer Res., 52, 3483-3485.
24. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, Ohtsuka E and Nishimura S. (1987). Nature, 327, 77-79.
25. Kunkel TA and Alexander PS. (1986). J. Biol. Chem., 261, 160-166.
26. Lewis JG and Adams DO. (1985). Cancer Res., 45, 1270-1275.
27. McCoy MS, Bargmann CI and Weinberg RA. (1984). Mol. Cell. Biol., 4, 1577-1582.
28. Mitra G, Pauly GT, Kumar R, Pei GK, Hughes SH, Moschel RC and Barbacid M. (1989). Proc. Natl. Acad. Sci. USA, 86, 8650-8654.
29. Moriya M. (1993). Proc. Natl. Acad. Sci. USA, 90, 1122-1126.
30. Moriya M, Ou C, Bodepudi V, Johnson F, Takeshita M and Grollman AP. (1991). Mutation Res., 254, 281-288.
31. Nassi-Calo L, Mello-Filho C and Meneghini R. (1989). Carcinogenesis, 10, 1055-1057.
32. Orita S, Higashi T, Mori T and Miyoshi J. (1991). Virus Genes, 5, 75-79.
33. Rodenhuis S. (1992). Semin. Cancer Biol., 3, 241-247.
34. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG and Cochrane CG. (1986a). J. Clin. Invest., 77, 1312-1320.
35. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA and Cochrane CG. (1986b). Proc. Natl. Acad. Sci. USA, 83, 4908-4912.
36. Schraufstatter IU, Hyslop PA, Jackson J and Cochrane CG. (1988). J. Clin. Invest., 82, 1040-1048.
37. Seeburg PH, Colby WW, Capon DJ, Goeddel DV and Levinson AD. (1984). Nature, 312, 71-75.
38. Shibutani S, Takeshita M and Grollman AP. (1991). Nature, 349, 431-434.
39. Srivastava SK, Yuasa Y, Reynolds SH and Aaronson SA. (1985). Proc. Natl. Acad. Sci. USA, 82, 38-42.
40. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T. (1990). Oncogene, 5, 1037-1043.
41. Vousden KH, Bos JL, Marshall CJ and Phillips DH. (1986). Proc. Natl. Acad. Sci. USA, 83, 1222-1226.
42. Weitberg AB, Weitzman SA, Destrempes M, Latt SA and Stossel TP. (1983). New Eng. J. Med., 308, 26-30.
43. Weitzman SA and Gordon LI. (1990). Blood, 76, 655-663.
44. Weitzman SA and Stossel TP. (1982). J. Immunol., 128, 2770-2772.
45. Weitzman SA, Weitberg AB, Clark EP and Stossel TP. (1985). Science, 227, 1231-1233.
46. Wood ML, Dizdaroglu M, Gajewski E and Essigmann JM. (1990). Biochemistry, 29, 7024-7032.
47. Zimmerman R and Cerutti P. (1984). Proc. Natl. Acad. Sci. USA, 81, 2085-2087.